Ma et al. found that African American breast cancer patients had a higher frequency of truncating mutations (51%) in the promoter region of HGF compared to Caucasian breast cancer patients (15%), and these mutations were shown to result in increased expression of HGF in breast cancer tissue. The gene discussed is HGF; the disease is breast cancer.